Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	adenylate cyclase regulator activity	RAF1 GRM7	1.54e-04	9	42	2	GO:0010854
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF5 PRAMEF26 PRAMEF6	2.10e-04	55	42	3	GO:0042974
GeneOntologyMolecularFunction	tubulin binding	CCDC69 SPIRE1 DIAPH3 NF1 DCDC1 NLRP5	2.56e-04	428	42	6	GO:0015631
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	ZNHIT6 CREBBP SMYD3	3.61e-04	66	42	3	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	ZNHIT6 CREBBP SMYD3	3.61e-04	66	42	3	GO:0001098
GeneOntologyMolecularFunction	glycerophospholipid flippase activity	ATP10B ATP11B	3.87e-04	14	42	2	GO:0140333
GeneOntologyMolecularFunction	microtubule binding	CCDC69 SPIRE1 DIAPH3 NF1 DCDC1	4.50e-04	308	42	5	GO:0008017
GeneOntologyMolecularFunction	flippase activity	ATP10B ATP11B	5.76e-04	17	42	2	GO:0140327
GeneOntologyMolecularFunction	cyclase regulator activity	RAF1 GRM7	6.47e-04	18	42	2	GO:0010851
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF5 PRAMEF26 PRAMEF6	6.83e-04	82	42	3	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	PRAMEF5 PRAMEF26 PRAMEF6	1.05e-03	95	42	3	GO:0140767
GeneOntologyMolecularFunction	MAP kinase kinase kinase activity	RAF1 ARAF	1.47e-03	27	42	2	GO:0004709
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor binding	ZNHIT6 CREBBP	1.47e-03	27	42	2	GO:0001091
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ATP10B ATP11B	1.58e-03	28	42	2	GO:0140326
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	RAF1 CDC42BPG ARAF GRK4 MKNK1	2.34e-03	446	42	5	GO:0004674
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF5 PRAMEF26 PRAMEF6	1.23e-04	47	43	3	GO:0031462
GeneOntologyCellularComponent	cleavage furrow	SPIRE1 PSD2 DIAPH3	2.68e-04	61	43	3	GO:0032154
GeneOntologyCellularComponent	phospholipid-translocating ATPase complex	ATP10B ATP11B	3.70e-04	14	43	2	GO:1990531
GeneOntologyCellularComponent	cell division site	SPIRE1 PSD2 DIAPH3	5.96e-04	80	43	3	GO:0032153
Domain	RBD	RAF1 ARAF	6.67e-05	6	40	2	PF02196
Domain	RBD	RAF1 ARAF	9.33e-05	7	40	2	SM00455
Domain	RBD_dom	RAF1 ARAF	9.33e-05	7	40	2	IPR003116
Domain	RBD	RAF1 ARAF	9.33e-05	7	40	2	PS50898
Domain	C1_1	RAF1 CDC42BPG ARAF	2.46e-04	57	40	3	PF00130
Domain	ZF_DAG_PE_1	RAF1 CDC42BPG ARAF	3.46e-04	64	40	3	PS00479
Domain	ZF_DAG_PE_2	RAF1 CDC42BPG ARAF	3.46e-04	64	40	3	PS50081
Domain	C1	RAF1 CDC42BPG ARAF	3.63e-04	65	40	3	SM00109
Domain	PE/DAG-bd	RAF1 CDC42BPG ARAF	3.79e-04	66	40	3	IPR002219
Domain	P_typ_ATPase_c	ATP10B ATP11B	4.00e-04	14	40	2	IPR032630
Domain	P-type_ATPase_N	ATP10B ATP11B	4.00e-04	14	40	2	IPR032631
Domain	P-type_ATPase_IV	ATP10B ATP11B	4.00e-04	14	40	2	IPR006539
Domain	PhoLip_ATPase_C	ATP10B ATP11B	4.00e-04	14	40	2	PF16212
Domain	PhoLip_ATPase_N	ATP10B ATP11B	4.00e-04	14	40	2	PF16209
Domain	PRAME_family	PRAMEF5 PRAMEF6	7.47e-04	19	40	2	IPR026271
Domain	DAG/PE-bd	RAF1 ARAF	9.15e-04	21	40	2	IPR020454
Domain	Ser/Thr_kinase_AS	RAF1 CDC42BPG ARAF GRK4 MKNK1	9.42e-04	357	40	5	IPR008271
Domain	S_TKc	RAF1 CDC42BPG ARAF GRK4 MKNK1	9.66e-04	359	40	5	SM00220
Domain	PROTEIN_KINASE_ST	RAF1 CDC42BPG ARAF GRK4 MKNK1	1.00e-03	362	40	5	PS00108
Domain	DAPIN	NLRP2 NLRP5	1.01e-03	22	40	2	PS50824
Domain	DAPIN	NLRP2 NLRP5	1.01e-03	22	40	2	IPR004020
Domain	PYRIN	NLRP2 NLRP5	1.01e-03	22	40	2	SM01289
Domain	PYRIN	NLRP2 NLRP5	1.01e-03	22	40	2	PF02758
Domain	NACHT	NLRP2 NLRP5	1.10e-03	23	40	2	PS50837
Domain	NACHT_NTPase	NLRP2 NLRP5	1.10e-03	23	40	2	IPR007111
Domain	Protein_kinase_ATP_BS	RAF1 CDC42BPG ARAF GRK4 MKNK1	1.23e-03	379	40	5	IPR017441
Domain	Pkinase	RAF1 CDC42BPG ARAF GRK4 MKNK1	1.26e-03	381	40	5	PF00069
Domain	-	ATP10B ATP11B	2.13e-03	32	40	2	2.70.150.10
Domain	-	ATP10B ATP11B	2.13e-03	32	40	2	3.40.1110.10
Domain	ATPase_P-typ_cyto_domN	ATP10B ATP11B	2.54e-03	35	40	2	IPR023299
Domain	ATPase_P-typ_P_site	ATP10B ATP11B	2.69e-03	36	40	2	IPR018303
Domain	P_typ_ATPase	ATP10B ATP11B	2.69e-03	36	40	2	IPR001757
Domain	ATPASE_E1_E2	ATP10B ATP11B	2.69e-03	36	40	2	PS00154
Domain	PROTEIN_KINASE_ATP	RAF1 CDC42BPG ARAF GRK4 MKNK1	2.84e-03	459	40	5	PS00107
Domain	ATPase_P-typ_transduc_dom_A	ATP10B ATP11B	2.84e-03	37	40	2	IPR008250
Domain	E1-E2_ATPase	ATP10B ATP11B	2.84e-03	37	40	2	PF00122
Domain	Prot_kinase_dom	RAF1 CDC42BPG ARAF GRK4 MKNK1	3.73e-03	489	40	5	IPR000719
Domain	PROTEIN_KINASE_DOM	RAF1 CDC42BPG ARAF GRK4 MKNK1	3.86e-03	493	40	5	PS50011
Domain	-	PRAMEF5 NLRP2 PRAMEF6 NLRP5	4.81e-03	321	40	4	3.80.10.10
Domain	L_dom-like	PRAMEF5 NLRP2 PRAMEF6 NLRP5	5.19e-03	328	40	4	IPR032675
Domain	Kinase-like_dom	RAF1 CDC42BPG ARAF GRK4 MKNK1	5.75e-03	542	40	5	IPR011009
Domain	Quinoprotein_ADH-like_supfam	OLFM1 NWD1	5.75e-03	53	40	2	IPR011047
Domain	LRR_6	NLRP2 NLRP5	6.18e-03	55	40	2	PF13516
Domain	AGC-kinase_C	CDC42BPG GRK4	6.40e-03	56	40	2	IPR000961
Domain	AGC_KINASE_CTER	CDC42BPG GRK4	6.40e-03	56	40	2	PS51285
Domain	S_TK_X	CDC42BPG GRK4	6.40e-03	56	40	2	SM00133
Domain	-	ATP10B ATP11B	8.29e-03	64	40	2	3.40.50.1000
Pathway	WP_PILOCYTIC_ASTROCYTOMA	RAF1 NF1	4.15e-05	6	24	2	M39584
Pathway	WP_FRAGILE_X_SYNDROME	RAF1 NF1 ARAF MKNK1	4.80e-05	121	24	4	M39804
Pathway	REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS	RAF1 ARAF	7.73e-05	8	24	2	M38999
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE	RAF1 ARAF	7.73e-05	8	24	2	M47933
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.24e-04	10	24	2	M47374
Pathway	KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.24e-04	10	24	2	M47420
Pathway	KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.24e-04	10	24	2	M47735
Pathway	KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.51e-04	11	24	2	M47370
Pathway	KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.51e-04	11	24	2	M47371
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.81e-04	12	24	2	M47369
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.81e-04	12	24	2	M47597
Pathway	KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.81e-04	12	24	2	M47815
Pathway	WP_MELANOMA	RAF1 NF1 ARAF	2.02e-04	68	24	3	M39811
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	RAF1 ATP10B ATP11B TTYH2	2.05e-04	176	24	4	MM15718
Pathway	KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.14e-04	13	24	2	M47589
Pathway	KEGG_LONG_TERM_POTENTIATION	RAF1 CREBBP ARAF	2.20e-04	70	24	3	M3115
Pathway	KEGG_RENAL_CELL_CARCINOMA	RAF1 CREBBP ARAF	2.20e-04	70	24	3	M13266
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	RAF1 ATP10B ATP11B TTYH2	2.38e-04	183	24	4	M997
Pathway	KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47488
Pathway	KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47364
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47365
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47366
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47378
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47383
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.50e-04	14	24	2	M47384
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47367
Pathway	KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47485
Pathway	KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47473
Pathway	KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47474
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47480
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47495
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47375
Pathway	KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47496
Pathway	KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47497
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47382
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47380
Pathway	KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47592
Pathway	KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47472
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47593
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47640
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47535
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	2.88e-04	15	24	2	M47531
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47363
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47373
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47483
Pathway	KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47381
Pathway	KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47682
Pathway	KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47804
Pathway	KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.29e-04	16	24	2	M47801
Pathway	REACTOME_ONCOGENIC_MAPK_SIGNALING	RAF1 NF1 ARAF	3.52e-04	82	24	3	M27626
Pathway	WP_GLIOBLASTOMA_SIGNALING	RAF1 NF1 ARAF	3.64e-04	83	24	3	M39637
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	3.72e-04	17	24	2	M47376
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY	RAF1 ARAF	3.72e-04	17	24	2	M47684
Pathway	WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE	RAF1 NF1 ARAF	3.77e-04	84	24	3	M39839
Pathway	WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS	RAF1 ARAF	4.18e-04	18	24	2	M39737
Pathway	KEGG_PROSTATE_CANCER	RAF1 CREBBP ARAF	4.47e-04	89	24	3	M13191
Pathway	KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY	RAF1 ARAF	4.67e-04	19	24	2	M47596
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	4.67e-04	19	24	2	M47793
Pathway	KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	5.72e-04	21	24	2	M47792
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	RAF1 CREBBP	5.72e-04	21	24	2	M27485
Pathway	KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	6.88e-04	23	24	2	M47799
Pathway	WP_MAPK_SIGNALING	RAF1 NF1 ARAF MKNK1	7.30e-04	246	24	4	M39597
Pathway	WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION	RAF1 MKNK1	8.14e-04	25	24	2	M39574
Pathway	WP_NOVEL_JUNDMP1_PATHWAY	RAF1 ARAF	8.14e-04	25	24	2	MM15984
Pathway	BIOCARTA_ERK_PATHWAY	RAF1 MKNK1	9.50e-04	27	24	2	M287
Pathway	WP_MAPK_CASCADE	RAF1 ARAF	1.02e-03	28	24	2	MM15976
Pathway	BIOCARTA_ERK_PATHWAY	RAF1 MKNK1	1.02e-03	28	24	2	MM1391
Pathway	WP_MAPK_CASCADE	RAF1 ARAF	1.42e-03	33	24	2	M39594
Pathway	REACTOME_RAF_ACTIVATION	RAF1 ARAF	1.51e-03	34	24	2	M27556
Pathway	KEGG_INSULIN_SIGNALING_PATHWAY	RAF1 ARAF MKNK1	1.57e-03	137	24	3	M18155
Pathway	REACTOME_RAF_ACTIVATION	RAF1 ARAF	1.60e-03	35	24	2	MM15271
Pathway	KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY	RAF1 ARAF	1.60e-03	35	24	2	M47379
Pathway	REACTOME_MAP2K_AND_MAPK_ACTIVATION	RAF1 ARAF	1.98e-03	39	24	2	MM15272
Pathway	WP_HEPATITIS_B_INFECTION	RAF1 CREBBP ARAF	2.07e-03	151	24	3	M39801
Pathway	WP_BLADDER_CANCER	RAF1 ARAF	2.08e-03	40	24	2	M39523
Pathway	REACTOME_MAP2K_AND_MAPK_ACTIVATION	RAF1 ARAF	2.08e-03	40	24	2	M27557
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	RAF1 ARAF	2.19e-03	41	24	2	M39655
Pathway	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	RAF1 ARAF	2.29e-03	42	24	2	MM15274
Pathway	KEGG_BLADDER_CANCER	RAF1 ARAF	2.29e-03	42	24	2	M19096
Pathway	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	RAF1 ARAF	2.40e-03	43	24	2	M27560
Pathway	REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS	RAF1 ARAF	2.63e-03	45	24	2	M27623
Pathway	WP_NOTCH_SIGNALING_WP268	CREBBP DTX3	2.63e-03	45	24	2	M39571
Pathway	WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586	RAF1 NF1	2.75e-03	46	24	2	M39661
Pathway	WP_NOTCH_SIGNALING_PATHWAY	CREBBP DTX3	2.75e-03	46	24	2	MM15971
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	CREBBP DTX3	2.87e-03	47	24	2	M7946
Pathway	BIOCARTA_NFAT_PATHWAY	RAF1 CREBBP	3.11e-03	49	24	2	MM1442
Pathway	WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING	RAF1 CREBBP	3.11e-03	49	24	2	M39683
Pathway	BIOCARTA_NFAT_PATHWAY	RAF1 CREBBP	3.37e-03	51	24	2	M2288
Pathway	PID_KIT_PATHWAY	RAF1 CREBBP	3.50e-03	52	24	2	M231
Pathway	KEGG_ENDOMETRIAL_CANCER	RAF1 ARAF	3.50e-03	52	24	2	M19877
Pathway	WP_TGFBETA_SIGNALING_PATHWAY	INHBA CREBBP	3.63e-03	53	24	2	MM15880
Pathway	KEGG_NON_SMALL_CELL_LUNG_CANCER	RAF1 ARAF	3.77e-03	54	24	2	M19818
Pathway	WP_TGFBETA_RECEPTOR_SIGNALING	INHBA CREBBP	3.90e-03	55	24	2	M39351
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP10B ATP11B	3.90e-03	55	24	2	M971
Pathway	KEGG_ACUTE_MYELOID_LEUKEMIA	RAF1 ARAF	4.19e-03	57	24	2	M19888
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP10B ATP11B	4.19e-03	57	24	2	MM15643
Pathway	WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS	INHBA CREBBP	4.48e-03	59	24	2	M39886
Pathway	WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA	RAF1 ARAF	4.48e-03	59	24	2	M39750
Pathway	KEGG_COLORECTAL_CANCER	RAF1 ARAF	4.94e-03	62	24	2	M14631
Pathway	WP_ENDOMETRIAL_CANCER	RAF1 ARAF	5.09e-03	63	24	2	M39623
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF5 PRAMEF26 NLRP2 PRAMEF6 NLRP5	2.77e-10	28	45	5	25089626
Pubmed	Mammalian Ras interacts directly with the serine/threonine kinase Raf.	RAF1 ARAF	1.64e-06	2	45	2	8334704
Pubmed	ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.	NF1 ARAF	1.64e-06	2	45	2	35613620
Pubmed	Mutations in NLRP2 and NLRP5 cause female infertility characterised by early embryonic arrest.	NLRP2 NLRP5	1.64e-06	2	45	2	30877238
Pubmed	A-Raf and C-Raf differentially regulate mechanobiological response of osteoblasts to guide mechanical stress-induced differentiation.	RAF1 ARAF	1.64e-06	2	45	2	27240957
Pubmed	A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression.	RAF1 ARAF	1.64e-06	2	45	2	15856007
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF5 PRAMEF26 PRAMEF6	3.06e-06	22	45	3	31729367
Pubmed	The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.	RAF1 NF1 ARAF TTYH2	3.60e-06	80	45	4	28205554
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF5 PRAMEF26 PRAMEF6	4.56e-06	25	45	3	37451217
Pubmed	RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.	RAF1 ARAF	4.91e-06	3	45	2	20130576
Pubmed	Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis.	RAF1 ARAF	4.91e-06	3	45	2	10704835
Pubmed	Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.	RAF1 NF1	4.91e-06	3	45	2	8628317
Pubmed	Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.	RAF1 ARAF	4.91e-06	3	45	2	14688025
Pubmed	ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.	RAF1 ARAF	4.91e-06	3	45	2	22926515
Pubmed	Expression of raf family proto-oncogenes in normal mouse tissues.	RAF1 ARAF	4.91e-06	3	45	2	1690378
Pubmed	Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.	RAF1 ARAF	4.91e-06	3	45	2	20052757
Pubmed	Endothelial apoptosis in Braf-deficient mice.	RAF1 ARAF	4.91e-06	3	45	2	9207797
Pubmed	Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.	RAF1 ARAF	4.91e-06	3	45	2	23352452
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF5 NLRP2 PRAMEF6	8.02e-06	30	45	3	38786026
Pubmed	Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins.	RAF1 ARAF	9.81e-06	4	45	2	8394352
Pubmed	Identification of interaction between MEK2 and A-Raf-1.	RAF1 ARAF	9.81e-06	4	45	2	11909642
Pubmed	Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.	RAF1 ARAF	9.81e-06	4	45	2	8621729
Pubmed	RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.	RAF1 NF1	9.81e-06	4	45	2	18592002
Pubmed	Aberrant expression of COT is related to recurrence of papillary thyroid cancer.	RAF1 ARAF	9.81e-06	4	45	2	25674762
Pubmed	Functional characterization of a PROTAC directed against BRAF mutant V600E.	RAF1 ARAF	9.81e-06	4	45	2	32778845
Pubmed	Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.	RAF1 NF1	9.81e-06	4	45	2	34184824
Pubmed	B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.	RAF1 ARAF	9.81e-06	4	45	2	7731720
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF5 PRAMEF26 PRAMEF6	1.29e-05	35	45	3	19389355
Pubmed	In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice.	RAF1 ARAF	1.63e-05	5	45	2	17219248
Pubmed	Germline gain-of-function mutations in RAF1 cause Noonan syndrome.	RAF1 ARAF	1.63e-05	5	45	2	17603482
Pubmed	Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors.	RAF1 ARAF	1.63e-05	5	45	2	24746704
Pubmed	Isoform-specific localization of A-RAF in mitochondria.	RAF1 ARAF	2.45e-05	6	45	2	10848612
Pubmed	Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.	RAF1 ARAF	2.45e-05	6	45	2	8157000
Pubmed	SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.	HELZ SMYD3	3.42e-05	7	45	2	15235609
Pubmed	Structural, expression, and evolutionary analysis of mouse CIAS1.	NLRP2 NLRP5	3.42e-05	7	45	2	15302403
Pubmed	Identification of Nore1 as a potential Ras effector.	RAF1 ARAF	3.42e-05	7	45	2	9488663
Pubmed	Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.	RAF1 ARAF	5.86e-05	9	45	2	19667065
Pubmed	AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.	RAF1 ARAF	5.86e-05	9	45	2	30595535
Pubmed	A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes.	RAF1 ARAF	5.86e-05	9	45	2	17967876
Pubmed	Phosphorylation-dependent interaction of kinesin light chain 2 and the 14-3-3 protein.	RAF1 ARAF	5.86e-05	9	45	2	11969417
Pubmed	Essential role of B-Raf in ERK activation during extraembryonic development.	RAF1 ARAF	7.32e-05	10	45	2	16432225
Pubmed	Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.	RAF1 NF1	8.94e-05	11	45	2	11435472
Pubmed	p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons.	RAF1 NF1	8.94e-05	11	45	2	9852579
Pubmed	ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner.	ATP10B ATP11B	1.07e-04	12	45	2	21914794
Pubmed	Differential expression of putative transbilayer amphipath transporters.	ATP10B ATP11B	1.27e-04	13	45	2	11015572
Pubmed	Cardiac deletion of Smyd2 is dispensable for mouse heart development.	HELZ SMYD3	1.27e-04	13	45	2	20305823
Pubmed	The genetics of NOD-like receptors in Crohn's disease.	NLRP2 NLRP5	1.47e-04	14	45	2	20403135
Pubmed	K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling.	RAF1 ARAF	1.47e-04	14	45	2	31015455
Pubmed	Raf Kinases Are Essential for Phosphate Induction of ERK1/2 Phosphorylation in Hypertrophic Chondrocytes and Normal Endochondral Bone Development.	RAF1 ARAF	1.47e-04	14	45	2	28073913
Pubmed	NALPs: a novel protein family involved in inflammation.	NLRP2 NLRP5	1.47e-04	14	45	2	12563287
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF5 PRAMEF6	2.20e-04	17	45	2	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF5 PRAMEF6	2.20e-04	17	45	2	37781892
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF5 PRAMEF6	2.47e-04	18	45	2	29731491
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF5 PRAMEF6	2.47e-04	18	45	2	23894331
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF5 PRAMEF6	2.47e-04	18	45	2	14675769
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF5 PRAMEF6	2.47e-04	18	45	2	12890732
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF5 PRAMEF6	2.47e-04	18	45	2	39181896
Pubmed	Genes, plasticity and mental retardation.	NF1 CREBBP	2.76e-04	19	45	2	18329113
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF5 PRAMEF6	2.76e-04	19	45	2	28604677
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF5 PRAMEF6	3.06e-04	20	45	2	26694250
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF5 PRAMEF6	3.06e-04	20	45	2	16580637
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF5 PRAMEF6	3.06e-04	20	45	2	21425410
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	RAF1 SPIRE1 ARAF	3.18e-04	102	45	3	15778465
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	HELZ NF1 ARAF	3.36e-04	104	45	3	31240132
Pubmed	Novel raf kinase protein-protein interactions found by an exhaustive yeast two-hybrid analysis.	RAF1 ARAF	4.07e-04	23	45	2	12620389
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF5 PRAMEF6	4.07e-04	23	45	2	19480014
Pubmed	Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences.	NDP NF1	4.82e-04	25	45	2	8889551
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF5 PRAMEF6	4.82e-04	25	45	2	12620990
Pubmed	Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.	CDC42BPG NF1 CREBBP ARAF	4.92e-04	283	45	4	21903422
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	PRAMEF5 PRAMEF6	5.22e-04	26	45	2	18500982
Pubmed	Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development.	CREBBP ARAF	5.22e-04	26	45	2	17177285
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	RAF1 HELZ ZFHX3 ZNHIT6 DCDC1 CREBBP ARAF	5.37e-04	1116	45	7	31753913
Pubmed	Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.	RAF1 ARAF	6.96e-04	30	45	2	34017080
Pubmed	Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome.	RAF1 ARAF	7.43e-04	31	45	2	8034307
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF5 PRAMEF6	7.92e-04	32	45	2	37889087
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAF1 HELZ SPIRE1 NF1 RFX7 ARAF	8.09e-04	861	45	6	36931259
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	PRAMEF5 NLRP2 PRAMEF6 NLRP5	8.34e-04	326	45	4	17015433
Pubmed	Tagging genes with cassette-exchange sites.	CDC42BPG HELZ RFX7 CREBBP	9.23e-04	335	45	4	15741177
Pubmed	Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.	RAF1 ARAF	1.00e-03	36	45	2	35379950
Pubmed	Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations.	DCDC1 HECTD4	1.06e-03	37	45	2	22797727
Pubmed	Lysine acetylation targets protein complexes and co-regulates major cellular functions.	RAF1 ARAF	1.12e-03	38	45	2	19608861
Pubmed	A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.	RAF1 ARAF SMYD3 DNAH17	1.24e-03	363	45	4	25036637
Interaction	EEF1AKMT3 interactions	RAF1 CDC42BPG HELZ ZNHIT6 NLRP2 ARAF SMYD3	7.84e-06	364	41	7	int:EEF1AKMT3
Interaction	TRMT61A interactions	RAF1 CDC42BPG HELZ GRK4	3.62e-05	92	41	4	int:TRMT61A
Interaction	WRAP53 interactions	RAF1 HELZ ZFHX3 NF1	3.94e-05	94	41	4	int:WRAP53
Cytoband	1p36.21	PRAMEF5 PRAMEF26 PRAMEF6	3.58e-05	63	46	3	1p36.21
GeneFamily	PRAME family	PRAMEF5 PRAMEF26 PRAMEF6	9.94e-06	24	32	3	686
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	RAF1 ARAF	3.02e-05	5	32	2	1157
GeneFamily	ATPase phospholipid transporting	ATP10B ATP11B	3.14e-04	15	32	2	1210
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	RAF1 ARAF	8.17e-04	24	32	2	654
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP2 NLRP5	8.88e-04	25	32	2	994
GeneFamily	NLR family	NLRP2 NLRP5	8.88e-04	25	32	2	666
ToppCell	facs-Marrow-Granulocytes-3m-Hematologic-MPP_Fraction_B\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 DIAPH3 ERI2 GRK4	1.98e-05	155	46	4	9b26ade19488511c72b64335011d2dcd81e8f167
ToppCell	facs-Marrow-Granulocytes-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 DIAPH3 ERI2 GRK4	1.98e-05	155	46	4	cd2f3ad4f131588325a667b6724e530d821fbe30
ToppCell	facs-Marrow-Granulocytes-3m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 DIAPH3 ERI2 GRK4	1.98e-05	155	46	4	4246709e27703b94529369abbed5763e4002e79d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OLFM1 ATP10B INHBA TTYH2	3.11e-05	174	46	4	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OLFM1 ATP10B INHBA TTYH2	3.11e-05	174	46	4	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
Disease	Retinal Neovascularization	NDP NF1	5.65e-06	3	41	2	C0035320
Disease	RASopathy	RAF1 NF1	1.96e-04	15	41	2	cv:C5555857
Disease	cortisol measurement	INHBA MKNK1	3.52e-04	20	41	2	EFO_0005843
Disease	renal system measurement, blood urea nitrogen measurement	DCDC1 HECTD4	4.28e-04	22	41	2	EFO_0004741, EFO_0004742
Disease	Noonan Syndrome	RAF1 NF1	5.10e-04	24	41	2	C0028326
Disease	mean arterial pressure	ZFHX3 NDP DCDC1 GRM7 HECTD4	6.15e-04	499	41	5	EFO_0006340
Disease	carbohydrate intake measurement	ZFHX3 HECTD4	1.03e-03	34	41	2	EFO_0010811
Disease	Cutaneous Melanoma	RAF1 NF1	1.49e-03	41	41	2	C0151779
Disease	high grade glioma (implicated_via_orthology)	RAF1 ARAF	1.72e-03	44	41	2	DOID:3070 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	PSD2 CREBBP GRK4	2.52e-03	195	41	3	DOID:1574 (implicated_via_orthology)
Disease	Antithrombotic agent use measurement	ZFHX3 HECTD4	2.67e-03	55	41	2	EFO_0009925

Protein segments in the cluster

Peptide	Gene	Start	Entry
KMTPPLCKCGRRSKR	ERI2	591	A8K979
PCFLRRKMPCLLKVA	ERC2-IT1	6	O76042
PSLMQLCRLRIRKCF	ASB9	256	Q96DX5
RCMADKTLPECSKLP	AFM	76	P43652
RNANCSLPSCQKMKR	CREBBP	1786	Q92793
MRCGLKEILPNLKCI	DIAPH3	366	Q9NSV4
LCCRSTPLQKSMIVK	ATP10B	1026	O94823
MGCRHSRLSSCKPPK	CCDC69	1	A6NI79
NLKSCCVPTKLRPMS	INHBA	386	P08476
MQRGKPCRALPTLKC	NWD1	1	Q149M9
CLMKALKVRGLQPEC	RAF1	81	P04049
KCLRCTSLMLGLGRQ	CDC42BPG	891	Q6DT37
LSPDGKRKTMLCLAC	DCDC1	1311	M0R2J8
ERLRACMQKLACGKL	OLFM1	216	Q99784
LSKRCAPRCPNDNMK	LY6L	71	H3BQJ8
GMKFLCEALRKPLCN	NLRP2	941	Q9NX02
RAMKTLCAKLRHPTC	NLRP5	796	P59047
ANTSCGLPLKMLRKT	HECTD4	116	Q9Y4D8
RAVLCCMQLKGKLQP	HELZ	96	P42694
SCRLCSFRKMRSPPK	MTERF2	11	Q49AM1
RALQVKKACPMCGRF	DTX3	191	Q8N9I9
LSKISSNCPKAMRRL	ARAF	531	P10398
SNCPKAMRRLLSDCL	ARAF	536	P10398
IVLKTLPCLVRMCSK	ARMC8	276	Q8IUR7
KTALQKLCMVRCLRP	DNAH17	3821	Q9UFH2
CQMSELRLLLLGKCR	GIMAP8	6	Q8ND71
NHPVGCKRKLAMSRC	ZNHIT6	206	Q9NWK9
AKRCCLQPRDAAKMP	CERS1	86	P27544
LLMGGCRNKCLSVLK	MAB21L2	241	Q9Y586
GLLKCRCRMLFNDLK	MARCHF4	36	Q9P2E8
KLLRVLTLMKFPCCV	GRM7	6	Q14831
CRMLLTKNPSKRLGC	GRK4	421	P32298
LCCKKLKILGMPFRN	PRAMEF26	86	H0Y7S4
LCSMKLSPPCKSRLA	MKNK1	431	Q9BUB5
RCLLGKEKLMRCSQC	SMYD3	51	Q9H7B4
LCCRMAPLQKAKVIR	ATP11B	791	Q9Y2G3
CCKKLKILGMPFRNI	PRAMEF6	181	Q5VXH4
VSSMKKFCRPLLPSC	PSD2	636	Q9BQI7
CLGLAKRSKCLLASM	TTYH2	231	Q9BSA4
RPVCSQCCKKMRLPS	SPIRE1	616	Q08AE8
CCKKLKILGMPFRNI	PRAMEF5	181	Q5TYX0
IGRMCKIIDKTCLSP	NF1	2051	P21359
QRTKCKSRCNEMLPG	RFX7	501	Q2KHR2
PLYKCSSKMVLLARC	NDP	51	Q00604
KLLQTRCKGRRMCPK	ZNF516-DT	91	Q6ZTR6
RCKGRRMCPKAGDQT	ZNF516-DT	96	Q6ZTR6
AIVMCITRKCPKNNR	TMEFF1	346	Q8IYR6
GKRKPILMCFLCKLS	ZFHX3	276	Q15911